Posted inBiotechnology
XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Posted inMedical Technology
Labcorp launches bird flu test amid first severe case in the US
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Posted inGenetics
The State of Cell and Gene Therapy 2025
Broadcast Date: Wednesday, January 29, 2025Time: 8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Posted inBiotechnology
Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’
Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas including drug…
Posted inBiotechnology
Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection
After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with…
Posted inBiotechnology
Editor’s Corner: Fierce Biotech’s 10 most-read stories of 2024
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting.…
Posted inGenetics
Deep Learning Slashes Cell Line Development Time
A biopharma company specializing in difficult-to-produce biologics has developed a deep learning model to rapidly predict protein expression using their…
Posted inGenetics
Optimizing TFF for mRNA Filtration
As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed…
Posted inGenetics
Starting Material Determines Cell-Based Product Quality
Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for…
Posted inGenetics
DNA-Based Vaccine Production Provides Best Shot at Profitability
Messenger RNA-based vaccine production has become a major industry focus, thanks to the success of jabs developed during the pandemic.…